DKS Co., Ltd. (4461) AI Stock Analysis

• Market Cap: ¥46.08B
• Dividend Yield: 1%
• Average Volume (3M): 48.27K
• Price to Earnings (P/E): 14.6
• Beta (1Y): 1.31
• Revenue Growth: 11.99%
• EPS Growth: 31.00%
• Country: JP
• Employees: 1,111
• Sector: Basic Materials
• Sector Strength: 68
• Industry: Chemicals - Specialty
• EPS (TTM): 102.81
• Shares Outstanding: 10,684,321
• 10 Day Avg. Volume: 61,620
• 30 Day Avg. Volume: 48,273
• PEG Ratio: -1.74
• Price to Book (P/B): 1.05
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥4,174.00
• Price Target Upside: -7.76% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 69 Neutral
• Price Target: ¥5,720.00 ▲(26.41%Upside)

DKS Co., Ltd. demonstrates strong financial performance with robust revenue growth and effective cash management, which significantly supports its stock score. Technical analysis indicates a strong upward trend, although overbought conditions could lead to volatility. Valuation metrics suggest the stock is fairly priced, but the dividend yield is relatively low. Overall, the company is well-positioned for future growth, though investors should be cautious of potential short-term price fluctuations.

DKS Co., Ltd. Business Overview & Revenue Model

Company Description

DKS Co., Ltd. (4461) is a Japanese company primarily engaged in the chemical industry. The company specializes in the production and sale of a wide range of chemical products, including surfactants, functional materials, and other chemical compounds. These products serve various sectors, including cosmetics, pharmaceuticals, agriculture, and industrial applications, highlighting the company's diverse involvement in multiple industries.

How the Company Makes Money

DKS Co., Ltd. generates revenue through the manufacture and sale of its chemical products. The company's key revenue streams include sales of surfactants, which are used extensively in personal care and household cleaning products, and functional materials that cater to electronics and industrial sectors. Partnerships with companies in cosmetics, pharmaceuticals, and agriculture further bolster its earnings, as DKS supplies essential chemical components to these industries. The company's focus on research and development enables it to innovate and meet the evolving demands of its clients, driving sustained revenue growth.

DKS Co., Ltd. Financial Statement Overview

Summary

DKS Co., Ltd. exhibits strong financial health with notable revenue growth and improved profitability margins. The balance sheet is well-managed, with a solid equity base and manageable debt levels. Cash flow trends are positive, showing effective cash conversion and reinvestment strategies.

Income Statement

DKS Co., Ltd. has demonstrated strong revenue growth with a 16.08% increase in revenue from 2024 to 2025. The Gross Profit Margin improved to 24.89%, showing effective cost management. EBIT and EBITDA margins have also improved to 7.31% and 11.85% respectively, indicating enhanced operational efficiency. Net Profit Margin increased to 3.53%, a positive trend from previous years, enhancing overall profitability.

Balance Sheet

The Debt-to-Equity Ratio is 0.81, suggesting a stable leverage position. The company's Return on Equity improved to 6.67%, reflecting efficient use of equity to generate profits. The Equity Ratio stands at 39.88%, indicating a solid financial structure with significant equity backing. There is a consistent increase in total assets, further strengthening the balance sheet.

Cash Flow

Operating Cash Flow to Net Income Ratio is strong at 2.91, showing robust cash generation relative to net income. Free Cash Flow grew by 17.41% from 2024 to 2025, indicating better capital management. The Free Cash Flow to Net Income Ratio is 2.08, emphasizing the company's ability to convert earnings into cash.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	73.25B	63.12B	65.08B	62.67B	59.14B
Gross Profit	18.24B	13.15B	12.96B	15.72B	15.18B
EBITDA	8.68B	5.85B	3.83B	8.21B	7.95B
Net Income	2.58B	1.17B	-407.00M	2.49B	2.56B
Balance Sheet
Total Assets	97.11B	94.54B	85.03B	86.47B	85.03B
Cash, Cash Equivalents and Short-Term Investments	16.75B	16.13B	9.13B	12.22B	11.60B
Total Debt	31.35B	35.14B	32.47B	30.87B	32.10B
Total Liabilities	52.60B	53.24B	46.73B	46.09B	47.63B
Stockholders Equity	38.73B	36.75B	34.35B	36.77B	34.65B
Cash Flow
Free Cash Flow	5.39B	4.59B	-2.11B	2.86B	557.00M
Operating Cash Flow	7.53B	7.09B	724.00M	5.52B	4.96B
Investing Cash Flow	-2.14B	-2.01B	-2.88B	-2.70B	-3.80B
Financing Cash Flow	-5.04B	1.65B	-1.03B	-2.34B	255.00M

DKS Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 4525.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4461, the sentiment is Positive. The current price of 4525 is above the 20-day moving average (MA) of 4162.25, above the 50-day MA of 3818.60, and above the 200-day MA of 3298.68, indicating a bullish trend. The MACD of 214.72 indicates Negative momentum. The RSI at 79.44 is Negative, neither overbought nor oversold. The STOCH value of 94.10 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4461.

DKS Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4094	79 Outperform	¥43.37B	18.42		3.43%	13.35%	36.31%
4611	78 Outperform	¥35.36B	3.77		3.94%	0.79%	104.86%
4112	74 Outperform	¥25.30B	7.75		4.41%	9.75%	28.00%
4464	73 Outperform	¥34.69B	11.75		2.72%	-0.44%	11.34%
4462	72 Outperform	¥28.85B	12.10		2.03%	15.27%	48.08%
4461	69 Neutral	¥46.08B	14.63		1.00%	11.99%	31.00%
Sector *	62 Neutral	$10.39B	9.84	1.51%	2.86%	2.35%	-34.25%

DKS Co., Ltd. Corporate Events

DKS Co., Ltd. Revises Financial Forecasts Upward Amid Strong Product Growth

DKS Co., Ltd. has revised its financial forecasts for the six months ending September 30, 2025, and the fiscal year ending March 31, 2026, reflecting a significant increase in expected profits. This upward revision is driven by strong growth in high-value-added products, despite uncertainties like U.S. tariff measures and exchange rate fluctuations. The company anticipates that profits for both the six-month period and the fiscal year will exceed initial estimates, indicating a positive impact on its operations and market positioning.

DKS Co., Ltd. Reports Strong Q1 Financial Performance and Revises Earnings Forecast

DKS Co., Ltd. reported a significant increase in its financial performance for the three months ended June 30, 2025, with net sales rising by 8.6% and operating income increasing by 62.8% year-on-year. The company revised its earnings forecast for the fiscal year ending March 31, 2026, indicating positive expectations for future growth, which may enhance its market positioning and stakeholder confidence.

DKS Co., Ltd. Completes Treasury Stock Disposition

DKS Co., Ltd. has announced the completion of payment procedures for the disposition of treasury stock under its restricted stock compensation plan. This move, resolved at the Board of Directors meeting on June 25, 2025, involves the disposal of 5,901 shares of common stock at a price of 3,810 yen per share, totaling 22,482,810 yen. The allotment is aimed at directors and audit & supervisory board members, reflecting the company’s commitment to aligning executive interests with shareholder value.

DKS Co., Ltd. Announces Treasury Stock Disposal Under Compensation Plan

DKS Co., Ltd. has announced the disposal of 5,901 shares of its treasury stock under a Restricted Stock Compensation Plan, as resolved by its Board of Directors. This move is part of a broader strategy to align the interests of its directors and supervisory board members with those of its shareholders, facilitating the achievement of targets set in its medium-term management plan, SMART 2030.

DKS Co., Ltd. Expands Business Focus to Include Agriculture

DKS Co., Ltd. has announced a proposal to amend its Articles of Incorporation to include agricultural products as part of its business objectives. This strategic move aims to strengthen its Life & Wellness business and promote new business development to address social issues, potentially enhancing its market position and offering new opportunities for stakeholders.

DKS Co., Ltd. Reports Strong Financial Growth for Fiscal Year 2025

DKS Co., Ltd. reported a significant increase in its financial performance for the fiscal year ended March 31, 2025, with net sales rising by 16.1% and operating income surging by 157.6%. This growth reflects the company’s strong market positioning and effective operational strategies, potentially benefiting stakeholders through increased dividends and a positive outlook for the upcoming fiscal year.

DKS Co., Ltd. Reports Extraordinary Loss Due to Impairment

DKS Co., Ltd. announced an extraordinary loss due to an impairment loss of ¥365 million on fixed assets held by its subsidiary, IKEDA YAKUSOU Co., Ltd., for the fourth quarter of the fiscal year ending March 31, 2025. This financial adjustment reflects the company’s adherence to the Accounting Standard for Impairment of Fixed Assets, impacting its financial results for the period.